Search research articles
Contact Us
Filters
Showing results (31-40 of 483) with videos related to
Page
of 49
Sort By:
Expert Review of Clinical Immunology
|
June 9, 2020
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
Yoshioki Yamasaki, Masataka Kuwana
International Journal of Hematology
|
January 28, 2025
Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia
Masataka Kuwana, Yoshiaki Tomiyama
Modern Rheumatology
|
June 6, 2022
A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting
Masataka Kuwana, Yuka Okazaki
Rheumatology (Oxford, England)
|
December 17, 2021
Outcomes in patients with systemic sclerosis undergoing early vs delayed intervention with potential disease-modifying therapies
Keina Yomono, Masataka Kuwana
Annals of the Rheumatic Diseases
|
January 20, 2012
Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols
Masataka Kuwana, Yuka Okazaki
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 2, 2006
[Immune mechanisms and novel therapeutic targets for ITP]
Masataka Kuwana, Yasuo Ikeda
Current Opinion in Rheumatology
|
September 10, 2010
Clinically amyopathic dermatomyositis
Shinji Sato, Masataka Kuwana
Expert Review of Respiratory Medicine
|
May 18, 2023
New paradigm in the treatment of myositis-associated interstitial lung disease
Takahisa Gono, Masataka Kuwana
Modern Rheumatology
|
November 22, 2019
Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease
Masataka Kuwana, Arata Azuma
Seminars in Hematology
|
May 14, 2013
CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia
Tetsuya Nishimoto, Masataka Kuwana
Page
of 49
Search research articles
Search
Showing results (31-40 of 483) with videos related to
Sort By:
Page
of 49
Expert Review of Clinical Immunology
|
June 9, 2020
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
Yoshioki Yamasaki, Masataka Kuwana
International Journal of Hematology
|
January 28, 2025
Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia
Masataka Kuwana, Yoshiaki Tomiyama
Modern Rheumatology
|
June 6, 2022
A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting
Masataka Kuwana, Yuka Okazaki
Rheumatology (Oxford, England)
|
December 17, 2021
Outcomes in patients with systemic sclerosis undergoing early vs delayed intervention with potential disease-modifying therapies
Keina Yomono, Masataka Kuwana
Annals of the Rheumatic Diseases
|
January 20, 2012
Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols
Masataka Kuwana, Yuka Okazaki
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 2, 2006
[Immune mechanisms and novel therapeutic targets for ITP]
Masataka Kuwana, Yasuo Ikeda
Current Opinion in Rheumatology
|
September 10, 2010
Clinically amyopathic dermatomyositis
Shinji Sato, Masataka Kuwana
Expert Review of Respiratory Medicine
|
May 18, 2023
New paradigm in the treatment of myositis-associated interstitial lung disease
Takahisa Gono, Masataka Kuwana
Modern Rheumatology
|
November 22, 2019
Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease
Masataka Kuwana, Arata Azuma
Seminars in Hematology
|
May 14, 2013
CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia
Tetsuya Nishimoto, Masataka Kuwana
Page
of 49